A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension

@inproceedings{Eveleth2012A4D,
  title={A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension},
  author={David D Eveleth and C. Starita and Charles S. Tressler},
  booktitle={BMC ophthalmology},
  year={2012}
}
BACKGROUND Several studies have investigated the effect of latanoprost on intraocular pressure (IOP). We compared the IOP-lowering effects of three higher concentrations of latanoprost with the commercially available concentration of 0.005% (50 μg/mL) in patients with primary open-angle glaucoma or ocular hypertension. METHODS Treatment-naive subjects or those receiving IOP-lowering medication with baseline IOP levels of ≥ 24 mmHg and ≤ 36 mmHg in at least one eye after washout were… CONTINUE READING
4 Citations
24 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 24 references

Similar Papers

Loading similar papers…